Xiaomei Luo
Shanghai Key Laboratory Of Maternal Fetal Medicine
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Engineered artificial antigen-presenting cells for tumor immunotherapy: Design strategies, clinical applications, and translational challenges.
Journal: Materials today. Bio
Published: March 04, 2026
Profiling of RUVBL2-Induced Transcriptome Alterations Highlights a Critical Role for Chromatin Remodeling in Ovarian Cancer.
Journal: BioFactors (Oxford, England)
Published: February 05, 2025
Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer.
Journal: Phytotherapy research : PTR
Published: November 16, 2024
Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.
Journal: European journal of medical research
Published: October 26, 2023
Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.
Journal: Biomolecules
Published: September 12, 2023
Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma.
Journal: Frontiers in endocrinology
Published: October 20, 2022
Analysis of m6A methylation patterns and tumor microenvironment in endometrial cancer.
Journal: Gene
Published: August 04, 2022
Cuproptosis patterns and tumor microenvironment in endometrial cancer.
Journal: Frontiers in genetics
Published: July 23, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026